Chauhan Balwantray C, Mikelberg Frederick S, Balaszi A Gordon, LeBlanc Raymond P, Lesk Mark R, Trope Graham E
Department of Ophthalmology and Visual Sciences, Dalhousie University, Second Floor, Centennial Bldg, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada B3H 2Y9.
Arch Ophthalmol. 2008 Aug;126(8):1030-6. doi: 10.1001/archopht.126.8.1030.
To determine systemic and ocular risk factors for visual field progression in open-angle glaucoma.
In the Canadian Glaucoma Study, a multicenter prospective longitudinal study of 258 patients (131 men and 127 women; median age, 65.0 years), baseline systemic measures included assessment of peripheral vasospasm and markers for hematopathology, coagulopathy, and immunopathology. Patients were followed up at 4-month intervals with perimetry, optic disc imaging, and a standardized interventional protocol for intraocular pressure control. Univariate and proportional hazards models were used to identify factors that predicted progression.
Visual field progression with standard automated perimetry.
Median follow-up was 5.3 years, with 167 patients (64.7%) completing 5 years or more and 67 patients (26.0%) completing 7 years or more. Abnormal baseline anticardiolipin antibody levels (hazard ratio [HR], 3.86; 95% confidence interval [CI], 1.60-9.31), higher baseline age (HR per year, 1.04; 95% CI, 1.01-1.07), female sex (HR, 1.94; 95% CI, 1.09-3.46), and higher mean follow-up intraocular pressure (HR per 1 mm Hg, 1.19; 95% CI, 1.05-1.36) before progression were associated with progression.
The Canadian Glaucoma Study identified 4 independent predictive factors for glaucomatous field progression. Application to Clinical Practice While confirming the importance of intraocular pressure in glaucoma progression, this study determined other risk factors that merit awareness.
确定开角型青光眼视野进展的全身和眼部危险因素。
在加拿大青光眼研究中,对258例患者(131例男性和127例女性;中位年龄65.0岁)进行了多中心前瞻性纵向研究,基线全身测量包括外周血管痉挛评估以及血液病理学、凝血病和免疫病理学标志物评估。患者每隔4个月接受一次视野检查、视盘成像以及标准化的眼压控制干预方案随访。采用单变量和比例风险模型来识别预测进展的因素。
标准自动视野检查的视野进展情况。
中位随访时间为5.3年,167例患者(64.7%)完成了5年或更长时间的随访,67例患者(26.0%)完成了7年或更长时间的随访。进展前基线抗心磷脂抗体水平异常(风险比[HR],3.86;95%置信区间[CI],1.60 - 9.31)、较高的基线年龄(每年HR,1.04;95% CI,1.01 - 1.07)、女性(HR,1.94;95% CI,1.09 - 3.46)以及进展前较高的平均随访眼压(每1 mmHg的HR,1.19;95% CI,1.05 - 1.36)与进展相关。
加拿大青光眼研究确定了4个青光眼视野进展的独立预测因素。应用于临床实践 本研究在确认眼压在青光眼进展中的重要性的同时,还确定了其他值得关注的危险因素。